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ABSTRACT  
Background: Audit and feedback (A&F) is a frequently used intervention aiming to support 
implementation of research evidence into clinical practice with positive, yet variable, effects.  
Our understanding of effective A&F has been limited by poor reporting and intervention 
heterogeneity. Our objective was to describe the extent of these issues.  Methods: Using a 
secondary review of A&F interventions and a consensus-based process to identify modifiable 
A&F elements, we examined intervention descriptions in 140 trials of A&F to quantify 
reporting limitations and describe the interventions.  Results: We identified 17 modifiable 
A&F intervention elements; 14 were examined to quantify reporting limitations and all 17 
were used to describe the interventions. Clear reporting of the elements ranged from 56% to 
97% with a median of 89%. There was considerable variation in A&F interventions with 51%  
for individual providers only, 92% targeting behaviour change and 79% targeting processes 
of care, 64% performed by the provider group, and 81% reporting aggregate patient data.  
Conclusions: Our process identified 17 A&F design elements, demonstrated gaps in 
reporting and helped understand the degree of variation in A&F interventions. 
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BACKGROUND  
Audit and feedback (A&F) is a frequently used implementation intervention that has been 
used in a wide variety of clinical contexts, and evaluated in three Cochrane reviews and 
updates over the past 30 years [1-3]. While the overall effects of these interventions on 
clinical practice are positive (median adjusted risk difference of 4.3% absolute increase), they 
are also highly variable (interquartile range of 0.5% to 16%) with no evidence of increasing 
effect sizes over time [1]. A cumulative analysis of estimates of the effect of A&F by year 
and a cumulative meta-regression for common effect modifiers suggested that little new 
knowledge about the effects of A&F and potential effect modifiers has been generated in the 
last decade despite publication of 32 new trials [4]. Unless substantial improvements are 
made in how we design, deliver, and test A&F interventions, they will continue to be sub-
optimal, working in some cases but not others, without clear knowledge as to why [5]. 
  A&F has been defined broadly as 'any summary of clinical performance of health 
care over a specified period of time' [1]. In practice, A&F is a group of interventions with 
substantial variability in design, content and delivery. Progress in designing and delivering 
consistently effective A&F, and our understanding of effect modifiers, has been limited in 
part by lack of consensus about key design elements of A&F interventions and systematic 
reviews that are hindered by poor reporting of interventions in primary studies [1]. Further 
evidence for the lack of understanding comes from the fact that hypothesized causal 
mechanisms of change are rarely stipulated for A&F interventions [6].  
 The 2012 Cochrane review of A&F showed that feedback format (verbal and written), 
source (a respected colleague or supervisor), frequency, improvement strategies (goal setting 
and action planning), and baseline performance explained some variation in the effectiveness 
of A&F.  These critical elements (i.e. the components that comprise the A&F intervention), 
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however, cannot be considered an exhaustive list of all the design decisions that need to be 
made when designing an A&F intervention. Five modifiable elements of A&F design have 
been identified by the Improved Clinical Effectiveness through Behavioural Research Group 
(ICEBeRG): content, intensity, method of delivery, duration, and context [7]. These 
elements, although limited in detail, provide a framework around which to consider design of 
A&F interventions.  In this study we aim to elaborate these elements and document how they 
are reported to inform A&F design decisions, help hypothesize causal mechanisms for 
change, and facilitate knowledge synthesis on the effectiveness and mechanism of A&F 
including effect modifiers. We had three objectives: 
1) Identify modifiable A&F-specific design elements 
2) Document the quality of reporting these elements  
3) Describe A&F interventions in current literature using this set of elements.  
 
METHODS 
We used a consensus-based process for developing the list of design elements, followed by 
an examination of existing A&F interventions to describe the quality of reporting and 
describe interventions in the existing literature. 
To develop a list of modifiable A&F design elements, we (the author team) used our 
collective expertise and knowledge of related literatures, including a coding frame of A&F 
features developed to select and apply theory to synthesize A&F evidence [8], to create a list 
of A&F design elements that we believe to be modifiable, and applicable to most A&F 
interventions. Our nine-member research team has expertise in designing and testing A&F 
interventions, behaviour change, and implementation science. The team also included both 
clinical expertise and experience as A&F recipients. Consensus was developed through 
several meetings including one face-to-face author meeting. The resulting list of 17 elements 
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was organized into the following 6 categories: to whom the A&F was delivered (2 items), 
what audited information was delivered (10 items), when it was delivered (i.e. what was the 
lag time between practice and feedback; 1 item), why it was provided (i.e. what was the 
rationale for using A&F; 1 item), how it was delivered (2 items), and how much  (i.e. the 
number of feedback instances delivered; 1 item). The specific 17 elements, written as the 
questions that were used for data extraction in the examination of the literature, are illustrated 
in Table 1.   
Table 1:  Modifiable A&F design elements 
Who 
1. was the feedback given to an individual, a group, or both 
2. was it given to the person in whom the practice change was desired (e.g. health care 
provider vs hospital administrator) 
What 
3. was there feedback about the processes of care (e.g. rate of antibiotic prescription) 
4. was there feedback about patient outcomes 
5. was there feedback about something other than processes of care or patient outcomes 
(if yes, specified) 
6. was the feedback about individual provider performance 
7. was the feedback about the performance of the provider group 
8. was the feedback about individual patient cases 
9. was the feedback about an aggregate of patient cases 
10. did the feedback identify a specific behavior(s) to be changed 
11. what was the comparison provided in the feedback (specified) 
12. were graphical elements included in the feedback 
When 
13. what was the lag between the time of the audit and the delivery of the feedback (days, 
weeks, months, years, a mix) 
Why 
14. what rationale was given for using A&F (specified) 
How 
15. was the feedback given face to face 
16. were providers explicitly asked to consider the implications the A&F had for their 
practice 
How much 
17. what was the total number of times the feedback was given (specified).  
 
We examined the A&F interventions evaluated in the 140 randomized controlled 
trials in the 2012 Cochrane review [1]. The Cochrane update spanned 1982 to 2011 and 
included the following databases: Cochrane Central Register of Controlled Trials, 
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MEDLINE, EMBASE, and CINAHL. For a full description of the methods used see Ivers et 
al., 2012[1]. To be included, trials had to examine and objectively measure either health 
professional practice or patient outcomes. Also, the interventions had to consist of a summary 
of clinical performance over a specified time period, with A&F a core aspect of the 
intervention for at least one intervention arm if a multifaceted intervention was used. As our 
interest was in exploring the broadest range of A&F interventions, the most complex study 
arm from each study was targeted for data abstraction. For example, if a study included 
control versus A&F versus enhanced A&F, we chose the latter.   
 A data extraction sheet and guide was developed in order to extract information on 
each of the elements in our list. The guide and sheet were piloted by three reviewers (HC, 
KC, MC) on five initial studies in the sample followed by a second pilot on 10 additional 
studies in the sample. Clarity improvements to terms and definitions of the elements were 
made after each of the pilots. KC and MC independently completed the variable extraction 
for each study with one reviewer reviewing all studies (HC). Disagreements were resolved 
through discussion and agreement.  
Fourteen of the 17 elements had the response options of ‘yes, no, unclear’, or 
‘specified, unclear’. These 14 elements, specifically the proportion of times the unclear 
response option was endorsed, formed the basis for determining the quality of reporting. For 
the remaining three elements, two did not have an ‘unclear’ response option as we considered 
that these questions were better answered as strictly yes/no questions (i.e. ‘was the A&F 
about something other than processes of care and patient outcomes’, and ‘were providers 
asked to specifically consider implications for their practice’). The third element that did not 
have an ‘unclear’ response option (i.e. the rationale for using A&F) was extracted by the 
reviewers as a description of the rationale in the paper from the reviewer’s viewpoint and was 
summarized post hoc (see below for a description of this process).  Four elements included a 
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specified description: what the feedback was about, the comparison provided, the rationale 
for using A&F, and the number of times the feedback was given. For these elements, the 
summary categories were developed post hoc by two team members (HC, KC) and confirmed 
by a third team member (JB). This process involved considering the range of specified 
responses and coding them into categories that best reflected the data.   
Descriptive statistics (e.g. frequencies, ranges, median) for each element were 
calculated. Quality of reporting was calculated by summarizing the total numbers of ‘unclear’ 
for each of the 14 elements that included an unclear response option; interrater reliability was 
analysed using the kappa statistic. 
 
RESULTS  
 The elaborated A&F design elements, frequencies (n [%]), and examples of who the 
A&F was delivered to, what A&F information was delivered, when, why, and how much, are 
shown in Table 2. 
 
Table 2.  A&F design elements, frequencies (n [%]), and examples of who the A&F was 
delivered to, what A&F information was delivered, when, why, and how much  
 
 
Elements Frequency Examples 
Who the A&F was delivered to 
(2) 
  
1. Was it delivered to: 
a) Individual providers only 
b) Groups of providers only 
c) Individuals and groups of 
providers 
 
 
Yes: 72 (51%) 
Yes: 25 (18%) 
Yes: 23 (16%) 
 
Unclear: 20 (14%) 
 
Sent to individual physicians by mail 
Given to practice group at a meeting  
Sent to both 
 
2. Was the A&F given to the 
person in whom the practice 
change was desired? 
Yes: 130 (92%) 
No: 6 (5%) 
Unclear: 4 (3%) 
Given to service provider (yes) 
versus to directors of services or a 
hospital administrator (no) 
What A&F information was 
delivered? (10) 
  
3. Processes of care? Yes: 111 (79%) Prescription rates, vaccination 
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Elements Frequency Examples 
No: 9 (6%) 
Unclear: 20 (15%) 
rates, compliance with guidelines 
4. Patient outcomes? Yes: 20 (14%) 
No: 102 (73%) 
Unclear: 18 (13%) 
Identification of patients with 
stroke, patient compliance 
5. Other? Yes: 45 (32%) 
No: 95 (68%) 
Costs of laboratory tests ordered 
6. Performance of individual 
provider? 
Yes: 81 (58%) 
No: 50 (36%) 
Unclear: 9 (6%) 
Individual prescription ordering 
7. Performance of provider 
group? 
Yes: 90 (64%) 
No: 38 (27%) 
Unclear: 12 (9%) 
Entire practice group prescription 
rates 
8. Individual patient cases? Yes: 35 (25%) 
No: 95 (68%) 
Unclear: 10 (7%) 
Patients identified who did not 
receive a particular preventive care 
action 
9. Aggregate of patient cases? Yes: 114 (81%) 
No: 15 (11%) 
Unclear: 11 (8%) 
Percent of the patients in the 
practice who did not receive 
guideline consistent care 
10. Was the specific behaviour to 
be changed identified? 
Yes: 124 (89%) 
No: 9 (6%) 
Unclear: 7 (5%) 
 
A&F on unnecessary test ordering 
in order to reduce test ordering 
(yes) versus A&F on costs of tests 
in order to reduce unnecessary test 
ordering (no) 
11. What was the comparison 
provided?  
a) Others previous 
performance alone 
b) Standardized guideline 
alone 
c) Own previous 
performance alone 
d) Others previous 
performance + 
standardized guideline 
e) Other 
 
 
 
Yes: 68 (49%) 
 
Yes: 15 (11%) 
 
Yes: 6 (4%) 
 
Yes: 6 (4%) 
 
 
Yes: 9 (6%) 
Unclear: 36 (26%) 
 
 
The average of the group  
 
A guideline 
 
Own performance in previous 
quarter  
Both the average of the group and 
a guideline 
 
Internal standard 
 
12. Graph presented? Yes: 47 (36%) 
No: 73 (52%) 
Unclear: 20 (14%) 
Line graph plotting monthly rates 
of lab test ordering for a practice 
group  
 
When was A&F delivered? (1)   
13. What was the lag time?   
a) Days 
b) Weeks 
c) Months 
d) Years 
e) Mix 
 
Yes: 6 (4%) 
Yes: 22 (16%)  
Yes: 46 (33%) 
Yes: 3 (2%) 
Yes: 2 (1%) 
 
Data from previous week 
Data from previous month 
Data from previous year 
Data from prior to previous year 
Mix 
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Elements Frequency Examples 
Unclear: 61 (44%) 
 
Why was A&F delivered? (1)   
14. Rationale for using A&F1 Empirical only: 51 
(37%) 
 
Intuitive: 39 (28%) 
 
 
No Rationale: 37 
(26%) 
 
Theory: 13 (9%) 
A single study or previous 
Cochrane Review of A&F cited. 
 
Un-referenced statement about 
A&F being effective.  
 
A&F appears for the first time in 
the intervention description.  
 
Using Social Cognitive Theory 
constructs to design the 
intervention. 
How was A&F delivered? (2)   
15. Face to face? Yes: 62 (44%) 
No: 68 (49%) 
Unclear: 10 (7%) 
Ground rounds, seminars, team 
meetings (compared to a mailout).  
16. Providers asked to consider 
implications of A&F on their 
practice? 
 
Yes: 32 (23%) 
No: 108 (77%) 
Meetings to make actionable plans 
based on A&F results  
How much A&F was delivered? 
(1) 
  
17. How much was given?  
a) Once 
b) Twice 
c) Three 
d) Four 
e) > Four2 
 
Yes: 33 (24%) 
Yes: 21 (15%) 
Yes: 13 (9%) 
Yes: 13 (9%) 
Yes: 27 (19%) 
Unclear: 33 (24%) 
 
One time mailout  
Feedback every 6 months for 1 
year  
Feedback every 2 weeks for 6 
weeks   
Quarterly feedback for 1 year 
Every 2 weeks for one year 
Notes: 
1
Empirical only – statement that A&F was chosen based on empirical or synthesis that 
it is effective. Reference required. 
Intuitive - general statements that A&F is worthwhile to include but not specified to be based 
on a named construct or theory; for example, A&F has not been used in this context so we are 
going to use it. 
No rationale - A&F not mentioned until it appears in the intervention 
Theory – a stated theory was used as a rationale for the intervention 
2
 Range was 5-78. 
 
 The kappa statistic ranged from .88 to .37 with a median of .62. For 8 items, the kappa 
statistic was > .6 (substantial agreement), and for five items, the kappa statistic was > .4 
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(moderate agreement) [9]. The low kappa for the remaining item is likely the result of a high 
prevalence of ‘yes’ responses [10]; raters agreed on 87% of the ratings. 
Quality of reporting 
Clear reporting of the 14 elements ranged from 56% to 97% with a median of 89%. 
Elements with the clearest reporting were whether the A&F was given to the person in whom 
the practice change was desired (97% clear), if the A&F addressed the behaviour to be 
changed (95% clear), and if the A&F was about a provider’s individual performance (94% 
clear). Elements that demonstrated the poorest reporting were the lag time between the audit 
and feedback components (56% clear), the nature of the comparison (74% clear), and the 
total number of times A&F was given (76% clear). 
 
Description of current A&F interventions 
 Who: A&F was primarily given to individuals only (51%), with 18% being given to a 
group and 16% given to both the group and the individuals in the group. The majority of the 
time (92%), the A&F was given to the target person rather than, for example, an 
administrator who was not the intervention target. 
 What: Rarely was feedback given on patient outcomes (14%); instead feedback was 
mostly about processes of care (79%) such as rate of antibiotic prescription. However, 32% 
of the time, feedback content included information other than processes of care and patient 
outcomes.  Most of this ‘other’ content included patient level data ([19/45] e.g. names of 
specific patients at risk for a condition) or cost data ([13/45] e.g. the costs of the prescribed 
medications). More than half of the studies (58%) used feedback that provided information 
about an individual’s own behaviour or patient cases. Feedback mostly presented aggregated 
patient data (81%), rather than feedback about individual patient’s care (25%). The most 
common comparison used was to peers’ performance or ‘others’ previous performance’ 
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(49%). Fifteen percent included a standardized guideline as a comparator, and 4% used the 
person’s own previous performance. Feedback mostly identified the specific behaviour to be 
changed (86%). An example of feedback that did not identify the behaviour to be changed 
included giving feedback on the total cost of inappropriate antibiotic prescription as opposed 
to the provider’s rate of inappropriate antibiotic prescriptions. Graphical representation of the 
data was found in only 36% of the interventions. 
 When: Lag time (the time between the collection of data for feedback and the 
provision of that data) was most commonly months (33%).  Rarely was the A&F provided 
based on a fast turnaround such as days or weeks. 
 Why: The rationale for using A&F ranged from empirical evidence only in 37% of 
the cases, an intuitive rationale in 28% of the cases and no rationale in 26% of the cases. As 
has been reported elsewhere, the remaining 9% of the cases used theory as the rationale for 
the intervention [6]. An example of an intuitive rationale was a statement that explained the 
rationale for why A&F might lead to behaviour change but was stated without a reference to 
empirical evidence or to a named theory or construct, e.g. “We thought feedback on generic 
prescribing to be less threatening to physicians than offering judgments on proper or 
improper use of drugs” [11] (p 194) or “The hypothesis underlying the hospital-specific 
feedback was that physicians and nurses were more likely to change their behaviour if made 
aware that their practices fell short in providing best care as defined by clinically meaningful 
quality criteria agreed upon in advance by credible authorities in their hospitals” [12] (p 
1637).  In the cases where no rationale was stated, A&F was not mentioned at all until it 
appeared in the intervention description. 
How: A&F was given face-to face-in about half of the studies (44%). In only 23% of the 
cases were providers explicitly asked to consider the implications that A&F had on their 
practice.  
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How much: A&F was delivered on one occasion 24% of the time, 15% twice, 9% three 
times, 9% four times, and 19% more than four times (range 5-78). 
  
DISCUSSION  
As an initial step towards the ultimate goal of facilitating the design and delivery of 
consistently effective A&F, we have developed a preliminary list of 17 design elements 
organized  according to the six categories of who the A&F was delivered to, what A&F 
information was delivered, when, why, how, and how much. Our quantification of related 
reporting limitations in primary studies indicated a range of clear reporting of 14 design 
elements from 56% to 97%.  A&F most often includes a report of processes of care (79%) 
performed by either the provider group (64%) and/or individual providers (58%), based on 
aggregate patient data (81%), and with a comparison to the performance of others within the 
group (49%). Less common was providing data on individual patient cases (25%), the use of 
a guideline for the comparison (15%), and the use of graphical elements to describe the data 
(36%). 
Quality reporting of interventions is essential for replication of study findings, 
understanding how and why an intervention might work, and for translating effective 
interventions into practice [13]. The proliferation of reporting guidance in the previous 
decade is, in a large part, a response to these needs.  For some elements in our findings, 
reporting was clearer than for others. For instance, 24% were unclear as to the total number 
of times feedback was given. Van Hoof and colleagues quantified reporting quality of 
another commonly used implementation intervention, educational outreach [14].  Based on 
25 identified design elements, reporting quality for each element ranged from 0-100%.  The 
reporting of A&F interventions in our review did not show a similarly wide range; however, 
none of our elements reached 100% reporting. In both of these studies of design elements for 
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common implementation interventions, additional work is needed to confirm the list of 
elements. 
While guidance exists for the reporting of interventions [13 15 16], none include the 
full range of elements we have proposed here for a detailed description of an A&F 
intervention. For example, the Template for Intervention Description and Replication 
(TIDieR) checklist includes reporting on the frequency with which the intervention is given, 
and to specify if provided individually or in a group, but does not specify reporting the nature 
of the comparison in A&F or whether it is based on processes of care or patient outcomes 
[13]. The development of reporting guidance for every type of implementation intervention is 
potentially unwieldy, but this study suggests a need to improve methods to achieve the detail 
necessary for reporting A&F interventions.  
Our process identified 17 elements in this family of interventions generally referred to 
as ‘A&F’. Our findings are consistent with the ICEBeRG framework and additionally enables 
a more precise and complete description of A&F interventions. The ICEBeRG element of 
content is consistent with our element of what will be delivered, intensity and duration with 
how much, and method of delivery with how. The only ICEBeRG element not included in 
our list of elements was context but given the lack of clarity as to the definition of context in 
the ICEBeRG list and the limited understanding of context in the field of health care practice 
improvement, we see this as a future area of focus. Ongoing efforts to examine the meaning 
of context [17] will potentially aid in this regard. 
Further work to examine the most and least endorsed responses for the 17 elements as 
compared to what is known about optimal A&F could provide an opportunity to examine 
where the typical A&F intervention might be sub-optimal and the generation of hypotheses 
for further testing. For example, theoretical perspectives indicate that A&F is more effective 
if the comparison is empirically-supported, such as a guideline, and if the intervention 
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includes multiple modalities (e.g., a graph plus text) [20]. The typical A&F found in this 
study indicated only 15% of studies using a guideline for the comparison and the use of 
graphical elements to describe the data in only 36% of the studies. Attention should be paid 
to the basis for the comparison and the presence of multiple modalities in A&F. Further 
studies should investigate best practices for multiple modalities and the identification of 
optimal comparisons. Current best evidence suggests that A&F will be more effective when 
delivered on more than one occasion [1], yet 24% of the studies in this review delivered A&F 
on only one occasion. Increased attention to how many times A&F is delivered is needed by 
A&F designers. 
In this review, the reported rationale for using A&F was rarely based on a theory or 
related constructs (9%); in 26% of trials, investigators reported no rationale for A&F at all. 
To date, theoretical predictions for designing and delivering optimal A&F interventions have 
rarely been incorporated into the design of A&F interventions - or at least, rarely stated in 
study reports [6 18]. For a full description of the extent and types of theories used in these 
140 trials of A&F see Colquhoun et al [6]. Of note in our study is the 28% of studies that 
used intuitive, but not explicitly theory-based, hypotheses about how the A&F might work. 
Although these hypotheses can be tested, we would argue that having the added value of 
defined constructs and construct relationships found in explicit theories offers the most 
effective way of increasing our understanding of the mechanisms of action by which A&F 
works. An additional 36% of the studies used empirical evidence as the rationale for using 
A&F. While some of this cited evidence were systematic reviews, we observed that many 
were single studies implying the misguided belief that success of A&F in one context will 
lead to success in another.  
 Several limitations of this study warrant discussion. In using the Cochrane update on 
A&F as our data set, we were limited to randomised controlled trials only.  Including other 
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study designs might have yielded additional information on A&F interventions.  We 
recommend that further work in this area includes a broader criteria related to study design. 
Also, we only looked at A&F in research studies; A&F used in routine health care settings 
(i.e., not within research settings) might yield additional information. The development of our 
list of modifiable A&F elements was expert-driven and preliminary. While we used available 
expertise and literature to develop this list, further refinement and validation is required. For 
example, a broader modified Delphi study incorporating views from international experts, 
A&F intervention designers, and those who have specific expertise in the theory and practice 
of A&F intervention delivery could be used to further develop our preliminary list of 
elements. We categorized our list of elements in order to aid understanding (e.g. who was the 
A&F given to, what was given) but other approaches to categorization could be considered. 
Due to the approach we used for response options, we were only able to investigate reporting 
quality for 14 of the 17 design elements. We described reporting quality as the number of 
unclear responses for each element, as opposed to a separate question regarding clarity of 
reporting, which could be considered. As we used the dataset from the Cochrane review on 
A&F, the studies ranged in years from 1980-2011. Given the proliferation of reporting 
guidance in the last decade [13 19], it is possible that examining the quality of reporting in 
the previous decade only would indicate improvements in reporting quality.  Future studies of 
reporting quality should consider analysis by decade. 
Based on this preliminary work, we propose that A&F intervention designers should, 
at a minimum, explicitly consider and offer justification for their decisions regarding who the 
A&F will be delivered to, what information will delivered, when it will be delivered (in 
relation to the collection of the data), why, how, and how much. Attention to all 17 elements 
is recommended or at least a decision made as to the most relevant elements to consider. 
Equal attention to the reporting of these elements is warranted.  
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CONCLUSION  
We have quantified reporting quality for 14 modifiable A&F elements based on 140 trials of 
A&F. We have also described typically employed A&F interventions for 17 elements and 
proposed a preliminary list of A&F elements to be considered when designing an A&F 
intervention. Our results provide a starting point for what should be considered in the design 
and reporting of A&F interventions.  
Incorporating both empirical and theoretical evidence into intervention designs would 
facilitate understanding of how to optimize this commonly applied intervention.  Future 
research needs to focus on further development of this set of A&F design elements, best 
practices for each of the elements, and the development of reporting guidance specific to 
A&F. Review teams should consider involving a broad range of study designs, reviews of 
A&F interventions delivered as a routine part of health care practice, and detailed 
examination of where current A&F interventions are suboptimal to guide the design of future 
A&F interventions. Recent suggestions have been made to consider A&F intervention 
elements as potential levers that should be considered and manipulated together [20]. For 
example, if A&F can only be delivered once, other elements should be considered for 
enhancement. A robust set of A&F design elements would facilitate these decisions, 
reporting quality, and the value of additional syntheses including investigation of effect 
modifiers.  
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